ATE365321T1 - Verfahren zur erkennung von entzündungen und entzündungsbedingungen - Google Patents

Verfahren zur erkennung von entzündungen und entzündungsbedingungen

Info

Publication number
ATE365321T1
ATE365321T1 AT01924324T AT01924324T ATE365321T1 AT E365321 T1 ATE365321 T1 AT E365321T1 AT 01924324 T AT01924324 T AT 01924324T AT 01924324 T AT01924324 T AT 01924324T AT E365321 T1 ATE365321 T1 AT E365321T1
Authority
AT
Austria
Prior art keywords
inflammatory conditions
methods
detecting inflammation
inflammatory
detecting
Prior art date
Application number
AT01924324T
Other languages
English (en)
Inventor
Paul Guyre
Peter Morganelli
Nicholas Goulding
Original Assignee
Dartmouth College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dartmouth College filed Critical Dartmouth College
Application granted granted Critical
Publication of ATE365321T1 publication Critical patent/ATE365321T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01924324T 2000-03-28 2001-03-27 Verfahren zur erkennung von entzündungen und entzündungsbedingungen ATE365321T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19252900P 2000-03-28 2000-03-28

Publications (1)

Publication Number Publication Date
ATE365321T1 true ATE365321T1 (de) 2007-07-15

Family

ID=22710051

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01924324T ATE365321T1 (de) 2000-03-28 2001-03-27 Verfahren zur erkennung von entzündungen und entzündungsbedingungen

Country Status (10)

Country Link
US (2) US20010041177A1 (de)
EP (1) EP1281083B1 (de)
JP (1) JP4777580B2 (de)
AT (1) ATE365321T1 (de)
AU (1) AU2001250987A1 (de)
CA (1) CA2404964A1 (de)
DE (1) DE60129015T2 (de)
DK (1) DK1281083T3 (de)
ES (1) ES2287115T3 (de)
WO (1) WO2001073435A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140069D1 (de) * 2000-10-16 2009-11-12 Cytoguide Aps Funktion eines haptoglobin-hämoglobin-rezeptors und anwendungszwecke dafür
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
EP1367393A1 (de) * 2002-05-27 2003-12-03 MacroZyme B.V. Verfahren zur Verwendung des CD 163 Wegs zur Modulation einer Immunantwort
US8116984B2 (en) * 2004-11-19 2012-02-14 Trillium Diagnostics, Llc Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FcγRI receptor (CD64)
EP1959956A2 (de) * 2005-12-15 2008-08-27 Naturemed Group Corporation Sinomenin-derivate, herstellung davon und verwendungen dafür
US20120252041A1 (en) 2009-10-12 2012-10-04 Region Midjylland Method of prognosis
US20140030735A1 (en) * 2011-03-07 2014-01-30 Temple University - Of The Commonwealth System Of Higher Education Biomarkers of chronic obstructive pulmonary disease
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
CN110114680A (zh) * 2016-05-05 2019-08-09 佰欧迪塞克斯公司 用于诊断肺癌的组合物、方法和试剂盒

Also Published As

Publication number Publication date
DK1281083T3 (da) 2007-10-22
US20030215885A1 (en) 2003-11-20
JP2003529080A (ja) 2003-09-30
EP1281083A4 (de) 2004-11-17
DE60129015T2 (de) 2008-02-21
ES2287115T3 (es) 2007-12-16
JP4777580B2 (ja) 2011-09-21
CA2404964A1 (en) 2001-10-04
WO2001073435A1 (en) 2001-10-04
EP1281083B1 (de) 2007-06-20
DE60129015D1 (de) 2007-08-02
EP1281083A1 (de) 2003-02-05
US7144710B2 (en) 2006-12-05
AU2001250987A1 (en) 2001-10-08
US20010041177A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
EP1118005A4 (de) Verfahren und vorrichtung zur auswertung von halbleiterscheiben
ATE209342T1 (de) Vorrichtung und verfahren zur gewinnung und erst- aufbereitung von gewebeproben für die molekulargenetische diagnostik
ATE540319T1 (de) Verfahren für die bestimmung von fk506
EP1075652A4 (de) Vorrichtung und verfahren zum prüfen von halbleiterscheiben
ATE333517T1 (de) Verfahren und sondenset zur erkennung von krebs
DE69831917D1 (de) Verbessertes Verfahren und Vorrichtung zur Waferprobendetektion
DE69535692D1 (de) Verfahren und Vorrichtung zur automatisierten Prüfung von Photomasken
DE69728017D1 (de) Vorrichtungen und Verfahren zur Erkennung von mehreren Analyten in Proben
EP1078247A4 (de) Verbesserte vorrichtung und methode zum durchführen von elektrochemilumineszenz-testmessungen
DE69724037D1 (de) Verfahren und Vorrichtung zur Erkennung des Inselbetriebs eines Wechselrichters
ATE508630T1 (de) Verfahren und gerät für das einfrieren und auftauen von biologischen proben
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
ATE232559T1 (de) Verfahren zur signalverstärkung
DE60133982D1 (de) Biosensor und verfahren zum analysieren von blutkomponenten
ATE444584T1 (de) Verfahren und anordnung zur ermittlung von zustandsgrössen
DE69932141D1 (de) Vorrichtung und Verfahren für mikrobiologische Untersuchungen
DE59907067D1 (de) Polymer-Werkstoff und Herstellungsverfahren, sowie System und Verfahren zur Materialüberprüfung von Polymer-Werkstoffen und Bauteilen
DE69929882D1 (de) Verfahren und vorrichtung zur nukleinsäurereinigung
DE69932845D1 (de) Methoden zur quantifizierung von hla-dr und cd11b
DE60235217D1 (de) Vorrichtung und Verfahren zur Feststellung von Turbomaschinenschaufelschaden
DE69927871D1 (de) Vorrichtung und Verfahren zur Unterscheidung von Erythrozyten in Urin
DE60217451D1 (de) Verfahren und Vorrichtung zur Überwachung der Konzentration des Sterilisierungsmittels in diffusionbeschränkten Bereichen
ATE365321T1 (de) Verfahren zur erkennung von entzündungen und entzündungsbedingungen
DE69726373D1 (de) Reifenmagnetisierungsmethode, nach dieser Methode magnetisierter Reifen sowie Vorrichtung zur Feststellung von Reifenumdrehungen
DE50010710D1 (de) Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties